1. Home
  2. WHD vs ARWR Comparison

WHD vs ARWR Comparison

Compare WHD & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHD
  • ARWR
  • Stock Information
  • Founded
  • WHD 2011
  • ARWR 2003
  • Country
  • WHD United States
  • ARWR United States
  • Employees
  • WHD N/A
  • ARWR N/A
  • Industry
  • WHD Metal Fabrications
  • ARWR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WHD Industrials
  • ARWR Health Care
  • Exchange
  • WHD Nasdaq
  • ARWR Nasdaq
  • Market Cap
  • WHD 2.9B
  • ARWR 2.5B
  • IPO Year
  • WHD 2018
  • ARWR 1993
  • Fundamental
  • Price
  • WHD $40.26
  • ARWR $29.13
  • Analyst Decision
  • WHD Buy
  • ARWR Strong Buy
  • Analyst Count
  • WHD 4
  • ARWR 8
  • Target Price
  • WHD $50.75
  • ARWR $47.75
  • AVG Volume (30 Days)
  • WHD 602.4K
  • ARWR 2.8M
  • Earning Date
  • WHD 10-29-2025
  • ARWR 08-07-2025
  • Dividend Yield
  • WHD 1.29%
  • ARWR N/A
  • EPS Growth
  • WHD N/A
  • ARWR N/A
  • EPS
  • WHD 2.67
  • ARWR N/A
  • Revenue
  • WHD $1,119,196,000.00
  • ARWR $572,976,000.00
  • Revenue This Year
  • WHD N/A
  • ARWR $21,619.52
  • Revenue Next Year
  • WHD $25.77
  • ARWR N/A
  • P/E Ratio
  • WHD $15.06
  • ARWR N/A
  • Revenue Growth
  • WHD N/A
  • ARWR 2816.20
  • 52 Week Low
  • WHD $33.80
  • ARWR $9.57
  • 52 Week High
  • WHD $70.01
  • ARWR $31.13
  • Technical
  • Relative Strength Index (RSI)
  • WHD 45.41
  • ARWR 70.38
  • Support Level
  • WHD $39.69
  • ARWR $28.12
  • Resistance Level
  • WHD $42.00
  • ARWR $31.13
  • Average True Range (ATR)
  • WHD 1.46
  • ARWR 1.58
  • MACD
  • WHD -0.09
  • ARWR 0.12
  • Stochastic Oscillator
  • WHD 14.21
  • ARWR 78.99

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: